liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database
Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Health Sciences. Region Östergötland, Anaesthetics, Operations and Specialty Surgery Center, Department of Otorhinolaryngology in Linköping.
Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Anaesthetics, Operations and Specialty Surgery Center, Department of Otorhinolaryngology in Linköping.
2015 (English)In: European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, E-ISSN 1434-4726, Vol. 272, no 11, 3169-3175 p.Article in journal (Refereed) Published
Abstract [en]

A randomized placebo-controlled study has demonstrated no effect of prednisolone in customary dosage on idiopathic sudden sensorineural hearing loss (ISSNHL). The aim of the present paper is to analyse a larger patient group by meta-analysis of data from the RCT together with a corresponding material drawn from the Swedish national database for ISSNHL. Data from 192 patients, 18-80 years with ISSNHL, were available. All had an acute hearing loss of at least 30 dB measured as PTA in the three most affected contiguous frequencies. All patients had been enrolled within one week after onset and evaluated by audiograms after 3 months. 45/99 (RCT) and 54/99 (the database) had been treated with prednisolone in tapering doses from 60 mg daily and 42/93 with placebo (RCT) or 51/93 with no treatment (the database). Primary outcome was the mean hearing improvement on day 90 for the different groups. A mean difference of greater than 10 dB improvement was required to demonstrate a treatment effect for prednisolone compared to placebo/no treatment. No significant difference was seen between the prednisolone group and placebo/no treatment (p = 0.06). Total recovery was 38 % in prednisolone group, 40 % in the placebo and 14 % in the no treatment group. Vertigo at the onset of hearing loss and age at onset had an equal negative prognostic value in all groups and signs of inflammation had a positive effect. Prednisolone in customary dosage does not influence recovery after ISSNHL.

Place, publisher, year, edition, pages
SPRINGER , 2015. Vol. 272, no 11, 3169-3175 p.
Keyword [en]
Idiopathic sudden sensorineural hearing loss; Sudden deafness; Prednisolone; Effect of treatment; Placebo; Vertigo
National Category
Otorhinolaryngology
Identifiers
URN: urn:nbn:se:liu:diva-122095DOI: 10.1007/s00405-014-3360-4ISI: 000361540600012PubMedID: 25351498OAI: oai:DiVA.org:liu-122095DiVA: diva2:861918
Available from: 2015-10-19 Created: 2015-10-19 Last updated: 2016-03-24

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hultcrantz, ElisabethNosrati Zare Noe, Ramesh
By organisation
Division of Neuro and Inflammation ScienceFaculty of Health SciencesDepartment of Otorhinolaryngology in LinköpingFaculty of Medicine and Health Sciences
In the same journal
European Archives of Oto-Rhino-Laryngology
Otorhinolaryngology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 100 hits
ReferencesLink to record
Permanent link

Direct link